- Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
- Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine
- Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
- Predictive Oncology to Participate in Upcoming Investor Conferences
- Predictive Oncology to Participate in Upcoming San Francisco Conferences
- Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
- Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
- Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
- Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
More ▼
Key statistics
On Friday, Predictive Oncology Inc (POAI:NAQ) closed at 1.63, 45.54% above the 52 week low of 1.12 set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.75 |
---|---|
High | 1.78 |
Low | 1.61 |
Bid | 1.62 |
Offer | 1.64 |
Previous close | 1.76 |
Average volume | 969.76k |
---|---|
Shares outstanding | 4.06m |
Free float | 3.92m |
P/E (TTM) | -- |
Market cap | 7.15m USD |
EPS (TTM) | -3.48 USD |
Data delayed at least 15 minutes, as of May 10 2024 20:52 BST.
More ▼